Xerox Holdings Corporation (XRX) Stock Price & Analysis
Xerox Holdings Corporation (XRX) closed at USD 2.79 on Wednesday, October 28, 2026, up 9.84% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 2.54; the Oct 28, 2026 session ranged USD 2.45–2.83 on volume of 7,739,838 shares. Market capitalization is $366.37M, with a 52-week range of USD 1.19–3.78 (NMS). Source: Nexqual, retrieved October 29, 2026 at 11:55 UTC.
Also available as compact Markdown for AI agents: nexqual.com/XRX.md
Latest Earnings Results (XRX)
Xerox Holdings Corporation (XRX) reported Q3 2026 results on Oct 29, 2026, 7:52:34 AM ET: adjusted EPS $0.02 vs. estimate -$0.12 (beat), revenue $1.87B vs. estimate $1.86B (beat). Guidance: Xerox lowered its full-year adjusted operating income and free cash flow guidance. Source: SEC 8-K filing. Nexqual published it 66 seconds after release. Read the SEC filing.
| Fiscal period | EPS (reported) | Revenue | Released | Source |
|---|---|---|---|---|
| Q3 2026 | $0.02 (adjusted (non-GAAP) diluted) | $1.87B | Oct 29, 2026, 7:52:34 AM ET · on Nexqual +66 seconds | SEC 8-K filing |
Reported actuals captured by Nexqual from SEC 8-K filings and company press releases; each figure confirmed by two independent extraction methods.
Key facts (XRX)
- Last four reported quarters (through Jun 30, 2026): revenue $7.76B, net income -$925M (-11.9% margin), free cash flow $163M (SEC filings).
- Analysts: Sell (mean 3.50 on a 1–5 scale) (4 analysts), mean target USD 3.5 (range 2.5–5).
- Total return with dividends: 1Y -14.9% vs S&P 500 +13.6%; 5Y -78.7% vs S&P 500 +79.8%.
- Next earnings: 2026-10-29, EPS estimate USD -0.12, revenue estimate $1.86B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (XRX)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $7.04B | $7.11B | $6.89B | $6.22B | $7.02B | $7.76B |
| Gross profit | $375M | $275M | — | — | — | — |
| Net income | -$455M | -$322M | $1.0M | -$1.32B | -$1.03B | -$925M |
| EPS (diluted) | -$2.56 | -$2.15 | -$0.09 | -$10.75 | -$8.25 | — |
| Free cash flow | $600M | $123M | $657M | $484M | $187M | $163M |
| Gross margin | 5.3% | 3.9% | — | — | — | — |
| Net margin | -6.5% | -4.5% | 0.0% | -21.2% | -14.7% | -11.9% |
| Revenue growth | +0.2% | +1.0% | -3.1% | -9.7% | +12.9% | — |
| Cash + short-term investments | $1.84B | $1.04B | $519M | $576M | $512M | — |
| Total debt | $4.25B | $3.73B | $3.28B | $3.40B | $4.25B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (XRX)
P/S 0.1x · EV/Sales 0.5x · P/FCF 2.2x · P/B 1.1x · FCF yield 44.49% · Earnings yield -252.48% · Dividend yield (paid, TTM) 7.92% · Net debt $3.73B · EV $4.09B
Analysts (XRX)
Consensus Sell (mean 3.50 on a 1–5 scale), 4 analysts; mean target USD 3.5 (low 2.5, high 5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-08 | Citigroup | Downgrade | Neutral → Sell | $3.45 → $2.5 |
| 2026-07-31 | Citigroup | Target raised | Neutral | $2.5 → $3.45 |
Total return (dividends reinvested) (XRX)
| 1Y (from 2025-10-29) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -14.9% | -78.7% |
| S&P 500 (SPY) | +13.6% | +79.8% |
| Per year | -14.9% | -26.6% |
| Volatility (annualized) | 89.0% | 62.1% |
| Max drawdown | -63.4% (Oct 2025→Apr 2026) | -93.2% (Jan 2022→Apr 2026) |
XRX major shareholder filing: Schedule 13D/A, Sep 8, 2026
STARTEEPO SICAV a.s., Frantisek Bostl filed a Schedule 13D/A with the SEC on Sep 8, 2026, reporting up to 7.34% of the class. A Schedule 13D is filed by an owner of more than 5% who may seek to influence the company. Item 4 (Purpose of Transaction), quoted from the filing:
The Reporting Persons have increased their investment based on their belief that the Common Stock is undervalued and represents an attractive investment opportunity. On September 7, 2026, the Reporting Persons issued an open letter (the "September Letter") to the Issuer's Board of Directors. In the September Letter, the Reporting Persons acknowledged the Issuer's operational and financial progress, but expressed concern that the Issuer remains deeply undervalued. The Reporting Persons urged the Board of Directors to provide more detailed financial reporting on Xerox Financial Services ("XFS") and to engage financial advisors to conduct a formal strategic review of XFS, evaluating all available alternatives to unlock value, including a joint venture, capital partnership, partial monetization, or sale. The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the full text of the September Letter, attached hereto as Exhibit 99.7 and incorporated herein by reference. The Reporting Persons may engage in discussions with the Issuer's management, board of directors, other stockholders of the Issuer and other relevant parties concerning the business, operations, board composition, management, strategy and future plans of the Issuer. …
Source: SEC EDGAR, Schedule 13D/A filed Sep 8, 2026. Quoted word for word; Nexqual adds no interpretation.
XRX earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Jun 30, 2026 | $0.38 | −$0.18 | Beat +$0.56 | — |
| — | Quarter ended Mar 31, 2026 | −$0.43 | −$0.27 | Miss −59.3% | — |
| — | Quarter ended Dec 31, 2025 | −$0.10 | $0.10 | Miss −$0.20 | — |
| — | Quarter ended Sep 30, 2025 | $0.20 | −$0.18 | Beat +$0.38 | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
XRX recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Oct 29, 2026 | 8-K | Quarterly results |
| Sep 8, 2026 | Schedule 13D/A | STARTEEPO SICAV a.s., Frantisek Bostl: 7.3% of shares, 5%+ holder that may seek to influence the company (amended) “The Reporting Persons have increased their investment based on their belief that the Common Stock is undervalued and represents an attractive investment opportunity. On September 7, 2026, the Reporting Persons issued an open letter (the "September Letter") to the Issuer's Board…” |
| Aug 6, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
| Jul 30, 2026 | 8-K | Quarterly results |
| Jul 13, 2026 | Schedule 13D/A | STARTEEPO Invest, investicni fond s promennym zakladnim kapitalem, a.s., Frantisek Bostl: 6.8% of shares, 5%+ holder that may seek to influence the company (amended) “The Reporting Persons increased their investment in the Issuer in light of their intention to engage more actively and constructively with the Issuer's management and Board of Directors regarding the Issuer's long-term strategy, capital allocation priorities, and opportunities…” |
| Jul 2, 2026 | 8-K | Director or executive officer change, or pay arrangement “On June 29, 2026, the Compensation and Human Capital Committee (the "Committee") of the Board of Directors (the "Board") of Xerox Holdings Corporation ("Xerox Holdings") and Xerox Corporation (together with Xerox Holdings, the "Company") approved the Xerox Holdings Corporation 2026-2028 Transformation Retention Award Plan (the "Retention Plan"), effective as of July 1, 2026. The Retention Plan is a limited-duration program designed to retain critical talent during the Company's multi-year transformation,…” |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
XRX suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Lexmark International II | “Any failure in our ability to transition to new geographies or to realize the anticipated benefits of Lexmark's customer relationships could harm our brand, prospects, operating results, and financial condition, and could have an adverse effect on our business.” |
| Partner | Fujifilm Business Innovation | “Fujifilm Business Innovation Corp. is our largest strategic sourcing partner, supporting products across our portfolio.” |
| Partner | XRX Brandco | “The Shared Services and License Agreement (the SSLA) entered pursuant to the joint venture arrangement with certain investors including certain funds and accounts managed by Angelo, Gordon & Co., L.P. may be terminated by XRX Brandco LLC upon certain events of default, in which case the Company's right to use the certain intellectual property, including the "Xerox" brand, would terminate, which could have a materi…” |
| Partner | SAP (SAP) | “In connection with the technology agreement with TCS, Xerox also entered into seven-year agreements with both SAP Limited (SAP), who will provide Xerox with a cloud-based digital ERP platform, and Microsoft, who will provide their Azure cloud platform services.” |
| Partner | Microsoft (MSFT) | “In connection with the technology agreement with TCS, Xerox also entered into seven-year agreements with both SAP Limited (SAP), who will provide Xerox with a cloud-based digital ERP platform, and Microsoft, who will provide their Azure cloud platform services.” |
| Partner | Verizon (VZ) | “During 2024, Xerox entered into a five-year agreement with Verizon Business Services (Verizon) to provide their Network as a Service (NaaS) solutions framework as part of Xerox's Reinvention.” |
| Competitor | HP Inc. (HPQ) | “The larger competitors in our print business include Brother, Canon, FUJIFILM Business Innovations Corp., HP Inc., Konica Minolta, Kyocera and Ricoh.” |
Quoted from the company's 10-K filed Mar 17, 2026.
Companies that name XRX in their SEC reports
| Relationship to XRX | Company | Filing | Sentence |
|---|---|---|---|
| related | CONDUENT Inc (CNDT) | 10-K Feb 19, 2026 | “Xerox Corporation ("Xerox") was historically classified as a related party due to significant shares of both Xerox and the Company being held by entities controlled by one individual.” |
XRX analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.12 | $0.05 | −$0.17 | $1.86B | 2 |
| Next quarter (ends Dec 2026) | $0.29 | $0.28 | +2.8% | $1.97B | 2 |
| Current fiscal year (ends Dec 2026) | $0.14 | $-0.28 | +$0.41 | $7.60B | 2 |
| Next fiscal year (ends Dec 2027) | $0.30 | $0.93 | -67.4% | $7.46B | 2 |
Key Statistics (as of October 29, 2026 at 11:55 UTC)
| Price | USD 2.79 |
|---|---|
| Change | ▲ 9.84% (up) |
| Previous Close | USD 2.54 |
| Open | USD 2.53 |
| Day Range | USD 2.45 – 2.83 |
| 52-Week Range | USD 1.19 – 3.78 |
| Volume | 7,739,838 shares |
| Market Cap | $366.37M |
| Exchange | NMS |
Technical Analysis (XRX)
Nexqual's technical model rates XRX "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 29, 2026 at 11:55 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.07 (neutral) |
| vs SMA50 | Below (USD 3.03) |
| MACD | -0.14 (negative) |
Analyst Ratings (XRX)
Wall Street analysts rate XRX "Sell" based on 4 analysts, with a mean price target of USD 3.5 (range USD 2.5–5), per Nexqual as of October 29, 2026 at 11:55 UTC.
| Consensus Rating | Sell |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 3.5 |
| High Target | USD 5 |
| Low Target | USD 2.5 |
| Buy / Hold / Sell | 1 / 1 / 2 |
Earnings (XRX)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD -0.12 |
| Revenue Estimate | $1.86B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.38 vs est -0.18 ▲ beat |
| 2026-03-31 | USD -0.43 vs est -0.27 ▼ miss |
| 2025-12-31 | USD -0.1 vs est 0.1 ▼ miss |
| 2025-09-30 | USD 0.2 vs est -0.18 ▲ beat |
Source: Nexqual, October 29, 2026 at 11:55 UTC.
Financials & Fundamentals (XRX)
| Total Revenue | $7.76B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +22.00% |
| Gross Margin | +30.55% |
| Operating Margin | +7.28% |
| Profit Margin | -11.92% |
| ROE | -97.11% |
| Debt / Equity | 7.79 |
| Current Ratio | 1.18 |
| Total Cash | $495.00M |
| Total Debt | $4.31B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $163.00M (2.1% of revenue) |
Source: Nexqual, October 29, 2026 at 11:55 UTC.
Financial Health Score (XRX)
Nexqual rates Xerox Holdings Corporation's overall financial health "Weak" across five dimensions, as of October 29, 2026 at 11:55 UTC.
| Growth | Solid — Revenue +13% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 31%, operating 7% (last 12 months) |
| Balance Sheet | Critical — $495M cash and investments vs $4.22B debt (Jun 2026, SEC) |
| Cash Flow | Mixed — FCF $163M (last 4 quarters to Jun 2026, SEC), slim 2.1% margin |
| Efficiency | Critical — ROE not meaningful (equity is 3.3% of assets); ROA -9.5% (last 4 quarters, SEC) |
Ownership (XRX)
| Insider Ownership | +16.55% |
|---|---|
| Institutional Ownership | +73.39% |
| Shares Outstanding | 131.31M |
| Float | 118.00M |
| Short % of Float | +32.56% |
Source: Nexqual, October 29, 2026 at 11:55 UTC.
Leadership (XRX)
Xerox Holdings Corporation is led by Louis J. Pastor, CEO & Director, per Nexqual as of October 29, 2026 at 11:55 UTC.
| CEO & Director | Louis J. Pastor |
|---|---|
| Executive VP & CFO | Charles Butler |
| Chief Revenue Officer | Jacques-Edouard Gueden |
| Director of Corporate Finance & Investor Relations Officer | Ann Pettrone |
| President of IT Solutions & CTO | Munu Gandhi |
Major Backers & Investors (XRX)
Notable institutional backers of Xerox Holdings Corporation include Shaw D.E. & Co., Inc., Two Sigma Investments, LP, Marshall Wace LLP, according to Nexqual as of October 29, 2026 at 11:55 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Shaw D.E. & Co., Inc. | 3.19% |
| Two Sigma Investments, LP | 3.07% |
| Marshall Wace LLP | 2.91% |
| Goldman Sachs | 2.13% |
| Charles Schwab Investment Management, Inc. | 1.85% |
| BW Gestao de Investimentos Ltda. | 1.82% |
| Charles Schwab | 0.84% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 5.94% |
| Vanguard Group | 5.69% |
| State Street | 3.27% |
Source: Nexqual, October 29, 2026 at 11:55 UTC.
From Xerox Holdings Corporation's Latest SEC 10-K Filing (filed 2026-03-17)
Key Strengths & Strategy (as disclosed to the SEC)
- As an authorized Microsoft Cloud Solution Provider, we facilitate the licensing, deployment, billing, and support of Microsoft 365, Azure, and related cloud services, offering flexible licensing options and consolidated management.
Legal & Regulatory Risks (Item 1A, quoted)
- Risks Related to our Acquisition of Lexmark
- Risks Related to Ownership of our Common Stock and our Warrants
- The market price for our Common Stock may be volatile and subject to future declines, and the value of an investment in our Common Stock and corresponding derivative securities may decline.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ACCO | Acco Brands Corporation | USD 4.38 | ▼ 2.23% |
| ACTG | Acacia Research Corporation | USD 4.4 | ▲ 2.33% |
| CXT | Crane NXT, Co. | USD 58.29 | ▼ 0.26% |
| NSC | Norfolk Southern Corporation | USD 338.09 | ▼ 0.49% |
| HWM | Howmet Aerospace Inc. | USD 195.19 | ▲ 1.67% |
| NOC | Northrop Grumman Corporation | USD 552.77 | ▲ 0.28% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 11:55 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt